Evidence map›Paper›PMID 36987774›Full record

ArticleThe Libyan journal of medicine2023

Clinical significance of serum CDC42 in the prediction of uremic vascular calcification incidence and progression.

Mingzhi Xu, Mingjiao Pan, Na An, Ruman Chen, Yafei Bai, Jiqing He, Chunli Wang, Yonghui Qi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Libyan journal of medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mingzhi XuBlood Purification Center, Hainan General Hospital (Hai-nan Affiliated Hospital of Hainan Medical University), Haikou, China.
Mingjiao PanBlood Purification Center, Hainan General Hospital (Hai-nan Affiliated Hospital of Hainan Medical University), Haikou, China.
Na AnBlood Purification Center, Hainan General Hospital (Hai-nan Affiliated Hospital of Hainan Medical University), Haikou, China.
Ruman ChenBlood Purification Center, Hainan General Hospital (Hai-nan Affiliated Hospital of Hainan Medical University), Haikou, China.
Yafei BaiBlood Purification Center, Hainan General Hospital (Hai-nan Affiliated Hospital of Hainan Medical University), Haikou, China.
Jiqing HeBlood Purification Center, Hainan General Hospital (Hai-nan Affiliated Hospital of Hainan Medical University), Haikou, China.
Chunli WangBlood Purification Center, Hainan General Hospital (Hai-nan Affiliated Hospital of Hainan Medical University), Haikou, China.
Yonghui QiBlood Purification Center, Hainan General Hospital (Hai-nan Affiliated Hospital of Hainan Medical University), Haikou, China.
Hainan General Hospital · CNHainan Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vascular calcification (VC) is prevalent in uremia patients, lacking effective molecular biomarkers. This study was conducted to explore the role of serum cell division cycle 42 (CDC42) in the diagnosis of uremic VC incidence and progression. We enrolled 104 uremia patients and selected arcus aortae calcification (AAC) as the outcome phenotype. Levels of CDC42, 1,25-dihydroxy vitamin D (1,25(OH)

Indexed as

UremiaVascular CalcificationBiomarkersClinical RelevanceHumansIncidenceBiomarkersarcus aortae calcificationCDC42diagnosislogistic regression analysisreceiver operator characteristic curveUremiavascular calcificationvascular calcification incidence and progression

Identifiers

PMID36987774
PMCPMC10062235
OpenAlexW4361287008

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.